Asset Management One Co., Ltd. Abb Vie Inc. Transaction History

Asset Management One Co., Ltd.

$27.7 Billion
Q3 2024

A detailed history of Asset Management One Co., Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 806,189 shares of ABBV stock, worth $142 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

806,189

Previous 801,292 0.61%

Holding current value

$142 Million

Previous $137 Million 15.84%

% of portfolio

0.58%

Previous 0.53%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$163.84 - $199.33 $802,324 - $976,119	4,897 Added 0.61%	806,189 $159 Million
Q2 2024 Jul 18, 2024	SELL	$154.79 - $180.76 $1.45 Million - $1.69 Million	-9,342 Reduced 1.15%	801,292 $137 Million
Q1 2024 May 02, 2024	SELL	$159.82 - $182.1 $3.71 Million - $4.22 Million	-23,187 Reduced 2.78%	810,634 $148 Million
Q4 2023 Jan 24, 2024	SELL	$137.6 - $154.97 $1.65 Million - $1.86 Million	-12,011 Reduced 1.42%	833,821 $129 Million
Q3 2023 Oct 19, 2023	SELL	$133.59 - $154.65 $692,530 - $801,705	-5,184 Reduced 0.61%	845,832 $126 Million
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $7.14 Million - $8.88 Million	53,868 Added 6.76%	851,016 $115 Million
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $1.16 Million - $1.33 Million	8,015 Added 1.02%	797,148 $127 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $1.91 Million - $2.29 Million	-13,825 Reduced 1.72%	789,133 $128 Million
Q3 2022 Nov 04, 2022	SELL	$134.21 - $153.93 $444,100 - $509,354	-3,309 Reduced 0.41%	802,958 $108 Million
Q2 2022 Jul 29, 2022	SELL	$137.62 - $174.96 $7.11 Million - $9.04 Million	-51,649 Reduced 6.02%	806,267 $123 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $5.9 Million - $7.32 Million	-44,675 Reduced 4.95%	857,916 $139 Million
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $224,098 - $283,549	2,086 Added 0.23%	902,591 $122 Million
Q3 2021 Nov 02, 2021	SELL	$106.4 - $120.78 $2.1 Million - $2.39 Million	-19,781 Reduced 2.15%	900,505 $97.1 Million
Q2 2021 Aug 03, 2021	SELL	$105.21 - $117.21 $2.05 Million - $2.29 Million	-19,510 Reduced 2.08%	920,286 $104 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $2.88 Million - $3.17 Million	-28,153 Reduced 2.91%	939,796 $102 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $595,867 - $804,484	-7,403 Reduced 0.76%	967,949 $101 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $4.37 Million - $5.13 Million	-50,907 Reduced 4.96%	975,352 $85.4 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $11.3 Million - $15.1 Million	153,524 Added 17.59%	1,026,259 $101 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $1.54 Million - $2.33 Million	-23,822 Reduced 2.66%	872,735 $66.5 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $1.15 Million - $1.44 Million	-15,962 Reduced 1.75%	896,557 $79.4 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $5,290 - $6,360	84 Added 0.01%	912,519 $69.1 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $4.5 Million - $5.75 Million	68,494 Added 8.12%	912,435 $66.4 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $138 Million - $162 Million	-1,789,523 Reduced 67.95%	843,941 $68 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $496,060 - $611,775	-6,372 Reduced 0.24%	2,633,464 $242 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $4.16 Million - $4.62 Million	-46,750 Reduced 1.74%	2,639,836 $250 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $1.2 Million - $1.43 Million	-13,417 Reduced 0.5%	2,686,586 $249 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $4.66 Million - $6.25 Million	50,701 Added 1.91%	2,700,003 $256 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $3.79 Million - $4.16 Million	42,354 Added 1.62%	2,649,302 $257 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $99,536 - $127,138	-1,425 Reduced 0.05%	2,606,948 $232 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,608,373	2,608,373 $189 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.

Account

Asset Management One Co., Ltd. Abb Vie Inc. Transaction History